| pubmed-article:8206400 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:8206400 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:8206400 | lifeskim:mentions | umls-concept:C0278579 | lld:lifeskim |
| pubmed-article:8206400 | lifeskim:mentions | umls-concept:C0079083 | lld:lifeskim |
| pubmed-article:8206400 | lifeskim:mentions | umls-concept:C0031928 | lld:lifeskim |
| pubmed-article:8206400 | lifeskim:mentions | umls-concept:C1561451 | lld:lifeskim |
| pubmed-article:8206400 | pubmed:issue | 3 | lld:pubmed |
| pubmed-article:8206400 | pubmed:dateCreated | 1994-7-14 | lld:pubmed |
| pubmed-article:8206400 | pubmed:abstractText | Twelve patients with recurrent squamous cell carcinoma of the cervix restricted to the pelvis were treated with intra-arterial infusion of carboplatin. The initial carboplatin dose was 300 mg/m2, every 4 weeks, and the dose was escalated to 450 mg/m2. Myelosuppression was the dose-limiting toxicity at the 450 mg/m2 dose. One patient died of treatment-related febrile neutropenia at that dose level. Two patients having received one cycle at 300 mg/m2 suffered grade 3 peripheral paresthesia. There were no objective responses but five patients had a subjective improvement of pain and performance status. | lld:pubmed |
| pubmed-article:8206400 | pubmed:language | eng | lld:pubmed |
| pubmed-article:8206400 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8206400 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:8206400 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:8206400 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:8206400 | pubmed:month | Jun | lld:pubmed |
| pubmed-article:8206400 | pubmed:issn | 0090-8258 | lld:pubmed |
| pubmed-article:8206400 | pubmed:author | pubmed-author:GenestPP | lld:pubmed |
| pubmed-article:8206400 | pubmed:author | pubmed-author:BertrandMM | lld:pubmed |
| pubmed-article:8206400 | pubmed:author | pubmed-author:VermaSS | lld:pubmed |
| pubmed-article:8206400 | pubmed:author | pubmed-author:DahrougeSS | lld:pubmed |
| pubmed-article:8206400 | pubmed:author | pubmed-author:PrefontaineMM | lld:pubmed |
| pubmed-article:8206400 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:8206400 | pubmed:volume | 53 | lld:pubmed |
| pubmed-article:8206400 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:8206400 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:8206400 | pubmed:pagination | 290-3 | lld:pubmed |
| pubmed-article:8206400 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:meshHeading | pubmed-meshheading:8206400-... | lld:pubmed |
| pubmed-article:8206400 | pubmed:year | 1994 | lld:pubmed |
| pubmed-article:8206400 | pubmed:articleTitle | A pilot study of intra-arterial carboplatin in patients with recurrent carcinoma of the cervix, postradiation. | lld:pubmed |
| pubmed-article:8206400 | pubmed:affiliation | Ottawa Regional Cancer Centre, Ontario, Canada. | lld:pubmed |
| pubmed-article:8206400 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:8206400 | pubmed:publicationType | Clinical Trial | lld:pubmed |
| pubmed-article:8206400 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
